Form 4: Edwards Lifesciences CEO Bernard J. Zovighian Reports Stock Disposal
SEC Filing
CEO Bernard J. Zovighian of Edwards Lifesciences Corp. reported the disposal of 2,854 shares of common stock to cover tax obligations.
Summary
- On May 11, 2024, Bernard J. Zovighian, CEO of Edwards Lifesciences Corp., disposed of 2,854 shares of common stock.
- The transaction was executed at a price of $86.72 per share.
- Following the transaction, Zovighian directly owns 76,834.9005 shares of common stock and indirectly owns 3,267.6552 shares through a 401(k).
- The transaction was reported on a Form 4 filing with the SEC.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to stock-based compensation.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine disposal of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 05/11/2024 | Date of stock disposal transaction |
| 05/13/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.